Heart Disease Trial, Recruiting NCT01429727 Sponsor: Mayo Clinic Condition: Heart Disease
Back to Heart Disease

Heart Disease Trial, Recruiting

NCT01429727
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been treated at Mayo Clinic and have been diagnosed with a spontaneous coronary artery dissection (SCAD) — a type of tear in a heart artery
  • Women who were pregnant or had given birth within the past 12 months at the time of their SCAD event
  • People who identify as Black/African American, Asian, American Indian or Alaska Native, Native Hawaiian or Other Pacific Islander, or any person of Hispanic ethnicity, as these groups are currently underrepresented in the registry
  • Men who have had a SCAD event
  • People who were younger than 30 years old at the time of their SCAD event
  • People whose SCAD event happened within the past 2 weeks
  • People with SCAD who are already enrolled in another Mayo Clinic SCAD research study
  • People with SCAD who have a family member who has also had a SCAD event

Who may not be able to join:

  • People with a history of SCAD who do not meet any of the inclusion criteria listed above will not be enrolled at this time (confirm with trial site)

A note for those who don't currently meet the criteria: People with a history of SCAD who are interested but do not meet the current criteria may have the option to leave their contact details so the trial site can reach out about future Mayo Clinic SCAD studies.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 6 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Marysia S Tweet, M.D., M.S., Mayo Clinic

Phone: 507-266-3180

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Registry
ClinicalTrials.gov
Start date
1 July 2011
Est. completion
1 December 2030

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Descriptive Data

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov